ConductScience.org, home

Paper42939751PubMed

Bile Acids and Their Receptors in Respiratory Diseases: Mechanistic and Therapeutic Perspectives.

Wan J and 9 others. Biomolecules, 2026.

Cite this record

ConductScience Library. Bile Acids and Their Receptors in Respiratory Diseases: Mechanistic and Therapeutic Perspectives. Papers, record 42939751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42939751

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Bile Acids and Their Receptors in Respiratory Diseases: Mechanistic and Therapeutic Perspectives.
Journal
Biomolecules
Year
2026
Publication types
Journal Article, Review
Revised in PubMed
2026-10-28

Source PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wan JJuanjuan
2Zong HHui
3He DDongdong
4Li DDingtao
5Yu JJing
6Wang GGuodong
7Liu LLiting
8Huang CChuanshenghttps://orcid.org/0009-0006-2027-0958
9Wang XXinchun
10Wang LLipinghttps://orcid.org/0009-0009-9526-7579

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Bile Acids and SaltsMajor topic
Respiratory Tract DiseasesMajor topic
Humans
Animals
Signal Transduction
Asthma

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
2023AB045, 2024AB071the projects of Corps Science and Technology Plan ProjectPubMed
82560831National Natural Science Foundation of ChinaPubMed

Source PubMed

Download CSV of grants

References135

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
130150987Bile Acids Activated Receptors Regulate Innate Immunity.Front Immunol2018https://conductscience.org/library/papers/30150987PubMed
235955473Interactive Relationships between Intestinal Flora and Bile Acids.Int J Mol Sci2022https://conductscience.org/library/papers/35955473PubMed
339317054Taurochenodeoxycholic acid ameliorates the Staphylococcus aureus infection-induced acute lung injury through toll-like receptor 2 in mice.Int Immunopharmacol2024https://conductscience.org/library/papers/39317054PubMed
437188530Suppression of Lung Oxidative Stress, Inflammation, and Fibrosis following Nitrogen Mustard Exposure by the Selective Farnesoid X Receptor Agonist Obeticholic Acid.J Pharmacol Exp Ther2024https://conductscience.org/library/papers/37188530PubMed
534022896RORγt inhibitors block both IL-17 and IL-22 conferring a potential advantage over anti-IL-17 alone to treat severe asthma.Respir Res2021https://conductscience.org/library/papers/34022896PubMed
631344409Ursodeoxycholic acid inhibits ENaC and Na/K pump activity to restore airway surface liquid height in cystic fibrosis bronchial epithelial cells.Steroids2019https://conductscience.org/library/papers/31344409PubMed
740985894FXR shapes an immunosuppressive microenvironment in PD-L1lo/- non-small cell lung cancer by upregulating HVEM.JCI Insight2025https://conductscience.org/library/papers/40985894PubMed
836076570Iguratimod ameliorates bleomycin-induced pulmonary fibrosis by inhibiting the EMT process and NLRP3 inflammasome activation.Biomed Pharmacother2022https://conductscience.org/library/papers/36076570PubMed
933252713Targeting the alternative bile acid synthetic pathway for metabolic diseases.Protein Cell2021https://conductscience.org/library/papers/33252713PubMed
1037515688Bile acid signaling in the regulation of whole body metabolic and immunological homeostasis.Sci China Life Sci2024https://conductscience.org/library/papers/37515688PubMed
1140378940Novel microbially transformed bile acids: Biosynthesis, structure, and function.Pharmacol Res2025https://conductscience.org/library/papers/40378940PubMed
1236470304FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2.Nature2023https://conductscience.org/library/papers/36470304PubMed
1312524422A G protein-coupled receptor responsive to bile acids.J Biol Chem2003https://conductscience.org/library/papers/12524422PubMed
1436016948Advances in the use of exosomes for the treatment of ALI/ARDS.Front Immunol2022https://conductscience.org/library/papers/36016948PubMed
1538280762Viral Pneumonias.Infect Dis Clin North Am2024https://conductscience.org/library/papers/38280762PubMed
1635797724Bile acid-induced lung injury: update of reverse translational biology.Am J Physiol Lung Cell Mol Physiol2022https://conductscience.org/library/papers/35797724PubMed
1737948864Ursodeoxycholic acid alleviates sepsis-induced lung injury by blocking PANoptosis via STING pathway.Int Immunopharmacol2023https://conductscience.org/library/papers/37948864PubMed
1836323778Inulin fibre promotes microbiota-derived bile acids and type 2 inflammation.Nature2022https://conductscience.org/library/papers/36323778PubMed
1926067554Chenodeoxycholic acid attenuates ovalbumin-induced airway inflammation in murine model of asthma by inhibiting the T(H)2 cytokines.Biochem Biophys Res Commun2015https://conductscience.org/library/papers/26067554PubMed
2028256288Beneficial effects of ursodeoxycholic acid via inhibition of airway remodelling, apoptosis of airway epithelial cells, and Th2 immune response in murine model of chronic asthma.Allergol Immunopathol (Madr)2017https://conductscience.org/library/papers/28256288PubMed

See all 135 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42939751

GET https://conductscience.org/api/papers/v1/42939751/references?page=2